Full Text (PDF)
Journal of Hospital Administration 7(2):p 55-58, July - December 2023. | DOI: na
Short Communication
Central Line: Associated Blood Stream Infection
Author Information
Licence:
Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
Journal of Hospital Administration 7(2):p 55-58, July - December 2023. | DOI: na
How Cite This Article:
Shibilamol C Baby /Central Line: Associated Blood Stream Infection/RFP Journal of Hospital Administration. 2023;7(2):55-58.Timeline
Received : April 28, 2023
Accepted : May 26, 2023
Published : December 25, 2023
Abstract
HAIs are resulting from complications of healthcare. They are linked with high morbidity and mortality. On any given day, 1 in 31 hospital patients has an HAI (an infection while being treated in a medical facility). It is one of the most emerging problems in health care. Additional infections occur in other healthcare settings. Seriously ill patients are particularly vulnerable to serious complications due to HAIs, likely due to factors such as progressively more invasive medical technology and complex medical procedures, increasing immunocompromised status and elderly age, and the rising incidence of antimicrobial resistance. The encouraging news is that many HAIs are preventable when evidence based guidelines are incorporated into patient care. Patients who get a CLABSI have a fever, and might also have red skin and soreness around the central line. If this happens, healthcare providers can do tests to learn if there is an infection present. Healthcare providers must follow a strict protocol when inserting the line to make sure the line remains sterile and a CLABSI does not occur. In addition to inserting the central line properly, healthcare providers must use stringent infection control practices each time they check the line or change the dressing.
References
- 1. www.ncbi.nlm.nih.gov
- 2. https://www.cdc.gov/hai/bsi/bsi.html
- 3. https://www.hopkinsmedicine.org
- 4. https://www.jointcommission.org
- 5. https://www.cdph.ca.gov
Data Sharing Statement
There are no additional data available. All raw data and code are available upon request.
Funding
This research received no funding.
Author Contributions
All authors contributed significantly to the work and approve its publication.
Ethics Declaration
This article does not involve any human or animal subjects, and therefore does not require ethics approval.
Acknowledgements
We would like to express our gratitude to the patients, their families, and all those who have contributed to this study.
Conflicts of Interest
No conflicts of interest in this work.
About this article
Cite this article
Shibilamol C Baby /Central Line: Associated Blood Stream Infection/RFP Journal of Hospital Administration. 2023;7(2):55-58.
Licence:
Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
| Received | Accepted | Published |
|---|---|---|
| April 28, 2023 | May 26, 2023 | December 25, 2023 |
DOI: na
Keywords
CLABSIWHOCDCPlCVCHAIsSearch for Similar Articles
Similar Articles
- Blue: Paradox A Confusing Risk Factor in Hospital and Community Waste Management
- Role of JIPMER Proforma in Burns Management
- Role of Fibrinogen Concentrate and Its Effect on Blood Loss in on Pump Cardiac S...
- From Sequencing to Prediction: Leveraging Next Generation Sequencing & Machine L...
- The Digital Personal Data Protection Act, 2023: Forensic and Medicolegal Implica...
Article Level Metrics
Last UpdatedSunday 15 November 2026, 05:51:29 (IST)
1647
Accesses
3
203
00
Citations
NA
NA
NA
Download citation
Article Keywords
Keyword Highlighting
Highlight selected keywords in the article text.
Timeline
| Received | April 28, 2023 |
| Accepted | May 26, 2023 |
| Published | December 25, 2023 |
licence
Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
